[1]
Memon, S. et al. 2019. Comparative Study of Oral versus Intravenous Iron Therapy in Patients of Chronic Renal Failure Receiving Recombinant Human Erythropoietin. Journal of Liaquat University of Medical & Health Sciences. 18, 01 (Apr. 2019), 42–46.